Literature DB >> 6259263

Inhibition of epidermal adenyl cyclase by lithium carbonate.

J J DiGiovanna, T Aoyagi, J R Taylor, K M Halprin.   

Abstract

An in vitro floating system was used to investigate the effect of lithium carbonate (Li2CO3) on the activity of adenyl cyclase in normal pig epidermis. Li2CO3 decreased the responsiveness of adenyl cyclase to stimulation by histamine, adenosine monophosphate (AMP) and epinephrine. This abnormality is similar but not identical to the previously described impaired responsiveness of adenyl cyclase to epinephrine and PGE2 in psoriatic plaques compared to normal adjacent skin. Involved and uninvolved skin from a psoriatic on lithium therapy demonstrated decreased responsiveness to in vitro stimulation by epinephrine, histamine and adenosine when compared to skin from psoriatics who were not on lithium therapy. These results are consistent with the observation that lithium therapy worsens psoriatic lesions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6259263     DOI: 10.1111/1523-1747.ep12526094

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

1.  Histological changes induced by application of lithium carbonate to mouse ear skin.

Authors:  X R Lin; T Huang; C M Yang
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  Development of a psoriasis-like syndrome following lithium therapy.

Authors:  K Hanada; M Tasaki; I Hashimoto; M Sone; T Yamaguchi
Journal:  Biol Trace Elem Res       Date:  1987-12       Impact factor: 3.738

Review 3.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

4.  Lithium chloride promotes host resistance against Pseudomonas aeruginosa keratitis.

Authors:  Kang Chen; Yongjian Wu; Min Zhu; Qiuchan Deng; Xinxin Nie; Meiyu Li; Minhao Wu; Xi Huang
Journal:  Mol Vis       Date:  2013-07-19       Impact factor: 2.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.